Inventor · disambiguated record
Joseph Edwin Low
Also filed as: LOW JOSEPH E · LOW JOSEPH EDWIN
10 granted patents·3 pending applications·271 citations·filing 1994–2019
91Inventor score
Top patents by PatentIndex Score
13 records- 0198US7326414B2Antibodies to M-CSFWARNER LAMBERT CO·Filed 2006·Granted Feb 5, 2008·86 cites·66 claims
- 0294US7728113B2Methods of treating arthritic conditions with antibodies to M-CSFAMGEN FREMONT INC·Filed 2007·Granted Jun 1, 2010·21 cites·27 claims
- 0391US7108852B2Methods of treating inflammation using antibodies to M-CSFWARNER LAMBERT CO·Filed 2001·Granted Sep 19, 2006·78 cites·7 claims
- 0489US7592430B2Antibodies to M-CSFAMGEN FREMONT·Filed 2004·Granted Sep 22, 2009·22 cites·52 claims
- 0582US6972298B2Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitorWARNER LAMBERT CO·Filed 2002·Granted Dec 6, 2005·24 cites·17 claims
- 0679US10280219B2Antibodies to M-CSFAMGEN FREMONT INC·Filed 2017·Granted May 7, 2019·1 cites·12 claims
- 0778US8188249B2Nucleic acid molecules encoding antibodies to M-CSFBEDIAN VAHE·Filed 2010·Granted May 29, 2012·2 cites·36 claims
- 0878US6548499B1Substituted quinoxaline derivatives as interleukin-8 receptor antagonistsMILLENNIUM PHARM INC·Filed 1999·Granted Apr 15, 2003·24 cites·20 claims
- 0969US2019202905A1Antibodies to m-csfAMGEN FREMONT INC·Filed 2019·Application pending·0 cites
- 1062US9718883B2Antibodies to M-CSFAMGEN FREMONT INC·Filed 2015·Granted Aug 1, 2017·0 cites·39 claims
- 1160US2012244167A1Antibodies to m-csfBEDIAN VAHE·Filed 2012·Application pending·0 cites
- 1259US2007059280A1Inhibitors of colony stimulating factorsWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 1348US5426113AMethod of preventing ulcer formation caused by nonsteroidal antiinflammatory drugs employing tetrazol-benzothiophene carboxamide compoundsWARNER LAMBERT CO·Filed 1994·Granted Jun 20, 1995·13 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Joseph Edwin Low files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →